Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2002
06/06/2002WO2001072973A3 Regulation of human heparanase-like enzyme
06/06/2002WO2001064884A3 G12l, a gene associated with the thermal response
06/06/2002WO2001049324A3 Novel colloid synthetic vectors for gene therapy
06/06/2002WO2001048209B1 Genes identified as required for proliferation of e. coli
06/06/2002WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
06/06/2002WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
06/06/2002WO2000022430A3 Neisseria genomic sequences and methods of their use
06/06/2002US20020068825 Polypeptide for use in the treatment of nervous system disorders
06/06/2002US20020068815 Nucleotide sequence coding receptor proteins for use in the treatment of urogential disorders
06/06/2002US20020068717 Methods and compositions for enhancing diffusion of therapeutic agents through tissue
06/06/2002US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody.
06/06/2002US20020068715 DNA construct comprising a sequence encoding an autoantigen associated with a pro-inflammatory, Th1-type T cell response, under the regulatory control of a promoter that is active in a mammalian host.
06/06/2002US20020068713 Genetic engineering of vascular grafts to resist disease
06/06/2002US20020068712 Decreasing inflammatory gaps in pulmonary endothelial cells
06/06/2002US20020068709 Modulating expression of a gene involved in malignant cell growth, comprising contacting with an oligonucleotide that comprises one or more locked nucleic acid units
06/06/2002US20020068707 Iga nephropathy-related genes
06/06/2002US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells
06/06/2002US20020068703 Modulating the interaction of immune complexes with tissue Fc receptors by introducing an inhibitor of an endogenous kinase
06/06/2002US20020068699 Clostridial toxin derivatives and methods for treating pain
06/06/2002US20020068698 13237, 18480, 2245 or 16228 novel human protein kinase molecules and uses therefor
06/06/2002US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides.
06/06/2002US20020068362 Increased transgene expression in retroviral vectors having a scaffold attachment region
06/06/2002US20020068354 Genetically engineering hematopoietic progenitor cells; obtain cells, transform with vector, monitor cells for expression of vector proteins
06/06/2002US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents
06/06/2002US20020068321 Splice choice antagonists as therapeutic agents
06/06/2002US20020068319 32 human secreted proteins
06/06/2002US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein
06/06/2002US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control
06/06/2002US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer
06/06/2002US20020068271 Methods for identifying agents capable of modulating protein kinase C theta (PKC0) activity
06/06/2002US20020068069 spsA polynucleotides and polypeptides
06/06/2002US20020068062 Inhibitors of the formation of soluble human CD23
06/06/2002US20020068052 Replication defective; use treating retinitis pigmentosa
06/06/2002US20020068050 Made by transfecting with an expression vector of a nucleotide sequence encoding an active agent such as cytokines or peptide hormones; use in transplantation to prevent tissue rejection, wound healing
06/06/2002US20020068049 Tissue specific adenoviral vectors
06/06/2002US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/06/2002US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers
06/06/2002US20020067880 Optical switch
06/06/2002DE10058847A1 Identifying interferon-responsive chronic myeloid leukemia patients, by detecting significant expression of an interferon-regulatory factor
06/06/2002CA2791831A1 Rna interference mediating small rna molecules
06/06/2002CA2433665A1 Projection against mycobacterial infections
06/06/2002CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
06/06/2002CA2430745A1 Master bone formation transcription factor: compositions and methods of use
06/06/2002CA2430625A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it
06/06/2002CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
06/06/2002CA2430351A1 Human protooncogene and protein encoded therein
06/06/2002CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease
06/06/2002CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol
06/06/2002CA2430331A1 Human cervical cancer 2 protooncogene and protein encoded therein
06/06/2002CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol
06/06/2002CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
06/06/2002CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies
06/06/2002CA2429819A1 Cytokine-like proteins
06/06/2002CA2429814A1 Rna interference mediating small rna molecules
06/06/2002CA2429803A1 Neutral and anionic colloidal particles for gene delivery
06/06/2002CA2429749A1 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
06/06/2002CA2429722A1 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
06/06/2002CA2429583A1 Methylenetetrahydrofolate reductase inhibitors and use thereof
06/06/2002CA2429469A1 Human elongase genes and uses thereof
06/06/2002CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
06/05/2002EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells
06/05/2002EP1211318A1 Paramyxoviruses comprising modified transcription start sequence
06/05/2002EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
06/05/2002EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
06/05/2002EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6
06/05/2002EP1210454A1 Antisense modulation of shp-1 expression
06/05/2002EP1210453A2 Hdac4 and hdac5 in the regulation of cardiac gene expression
06/05/2002EP1210447A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules
06/05/2002EP1210445A2 Recombinant microorganisms
06/05/2002EP1210444A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
06/05/2002EP1210439A1 Coxsackie virus-derived vector system for gene transfer
06/05/2002EP1210438A2 Ehrlichia canis genes and vaccines
06/05/2002EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY
06/05/2002EP1210433A2 Methods and compositions of a novel serine protease inhibitor
06/05/2002EP1210432A2 i IN VIVO /i TREATMENT OF JOINT DISEASE USING INTERLEUKIN-1 RECEPTOR ANTAGONISTS
06/05/2002EP1210430A2 Muc-1 derived peptides
06/05/2002EP1210427A1 Human narcolepsy gene
06/05/2002EP1210422A2 Human abc2 transporter and uses thereof
06/05/2002EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension
06/05/2002EP1210419A2 Human transmembrane proteins
06/05/2002EP1210405A2 Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same
06/05/2002EP1210370A1 Human tumor necrosis factor receptor tr16
06/05/2002EP1210365A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus
06/05/2002EP1210362A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
06/05/2002EP1210357A1 OLIGONUCLEOTIDE N3'$m(7)P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE
06/05/2002EP1210123A1 Single-stranded oligodeoxynucleotide mutational vectors
06/05/2002EP1210122A1 Gene expression with covalently modified polynucleotides
06/05/2002EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation
06/05/2002EP1210107A2 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons
06/05/2002EP1210106A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system
06/05/2002EP1210099A1 Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras
06/05/2002EP1210046A1 Enhanced wound coverage to enhance wound healing
06/05/2002EP1209971A1 Charge reversal of polyion complexes
06/05/2002CN1352696A Adipose-derived stem cell and Lattices
06/05/2002CN1352694A Novel system for regulating transgene expression
06/05/2002CN1352691A Human complement C3-degrading polypeptide from i(streptococcus pneumoniae)
06/05/2002CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer
06/04/2002US6399760 A nucleic acid encoding an amino acid sequence; diagnosis and therapy retinitis pigmentosa, night blindness
06/04/2002US6399755 A nucleic acid; diagnosis and therapy for human cancers